An application of propensity score matching using claims data.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMID 15651087)

Published in Pharmacoepidemiol Drug Saf on July 01, 2005

Authors

John D Seeger1, Paige L Williams, Alexander M Walker

Author Affiliations

1: Ingenix Epidemiology, Auburndale, Massachusetts 02466, USA. jseeger@epidemiology.com

Articles citing this

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding. Arch Intern Med (2011) 1.81

Bridging the inferential gap: the electronic health record and clinical evidence. Health Aff (Millwood) (2007) 1.81

Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol (2012) 1.76

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72

Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56

Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients. Circ Heart Fail (2012) 1.55

Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18

Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf (2013) 1.05

Comparing Outcomes for Youth in Treatment Foster Care and Family-style Group Care. Child Youth Serv Rev (2008) 0.95

Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study. Arthritis Rheumatol (2015) 0.92

Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. Gastroenterology (2015) 0.92

Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population. J Gen Intern Med (2015) 0.91

Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules. Epidemiology (2012) 0.91

Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations. Pharmacoepidemiol Drug Saf (2014) 0.91

Evaluation of a high-risk case management pilot program for Medicare beneficiaries with Medigap coverage. Popul Health Manag (2014) 0.90

Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. Osteoporos Int (2014) 0.89

Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention. Eur Heart J (2009) 0.89

Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial. Ann Intern Med (2009) 0.85

The impact of hospital-acquired infection on outcome in acute pancreatitis. Gastroenterology (2008) 0.83

Reduction of sampling bias of odds ratios for vertebral fractures using propensity scores. Osteoporos Int (2005) 0.83

Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance. Ther Adv Drug Saf (2012) 0.82

Allopurinol initiation and all-cause mortality in the general population. Ann Rheum Dis (2014) 0.82

Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S. PLoS One (2014) 0.81

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events. PLoS One (2014) 0.80

Glucosylsphingosine is a key biomarker of Gaucher disease. Am J Hematol (2016) 0.80

The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol (2013) 0.79

Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study. Medicine (Baltimore) (2015) 0.78

Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis (2015) 0.78

The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan. PLoS One (2015) 0.76

The Impact of Personalized Preventive Care on Health Care Quality, Utilization, and Expenditures. Popul Health Manag (2016) 0.75

The Impact of Loneliness on Quality of Life and Patient Satisfaction Among Older, Sicker Adults. Gerontol Geriatr Med (2015) 0.75

Does knee replacement surgery for osteoarthritis improve survival? The jury is still out. Ann Rheum Dis (2016) 0.75

The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data. PLoS One (2014) 0.75

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats. Clinicoecon Outcomes Res (2015) 0.75

Methods in pharmacoepidemiology: an invited series. Pharmacoepidemiol Drug Saf (2005) 0.75

Model Misspecification When Excluding Instrumental Variables From PS Models in Settings Where Instruments Modify the Effects of Covariates on Treatment. Epidemiol Method (2014) 0.75

Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study. Medicine (Baltimore) (2016) 0.75

The Zelnorm epidemiologic study (ZEST): a cohort study evaluating incidence of abdominal and pelvic surgery related to tegaserod treatment. BMC Gastroenterol (2012) 0.75

Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care. Diabetes Ther (2017) 0.75

Articles by these authors

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07

Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr (2010) 2.96

Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA (2006) 2.96

Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect (2008) 2.75

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73

Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med (2008) 2.59

Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect (2012) 2.43

Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol (2005) 2.31

Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med (2007) 2.31

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS (2012) 2.19

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS (2009) 2.16

Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf (2007) 2.04

The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease. Chest (2005) 2.04

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis (2003) 2.04

Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ (2002) 1.99

Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol (2007) 1.99

Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect (2012) 1.96

Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol (2007) 1.87

Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86

Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics (2009) 1.79

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74

The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71

Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis (2008) 1.60

Serum concentrations of polychlorinated biphenyls in relation to in vitro fertilization outcomes. Environ Health Perspect (2011) 1.60

Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res (2005) 1.60

NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine. Birth Defects Res B Dev Reprod Toxicol (2004) 1.57

Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. Clin Infect Dis (2004) 1.54

Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol (2005) 1.53

Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care (2011) 1.51

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther (2003) 1.49

Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48

Maternal urinary metabolites of Di-(2-Ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. Am J Epidemiol (2009) 1.47

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiol Drug Saf (2012) 1.46

Use of propensity score technique to account for exposure-related covariates: an example and lesson. Med Care (2007) 1.44

Challenges in using observational studies to evaluate adverse effects of treatment. N Engl J Med (2007) 1.42

Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J (2012) 1.41

Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy (2006) 1.41

Genetic modification of the association between peripubertal dioxin exposure and pubertal onset in a cohort of Russian boys. Environ Health Perspect (2012) 1.39

Effect of aprotinin on renal dysfunction. Lancet (2008) 1.39

The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology (2002) 1.38

The impact of wording in "Dear doctor" letters and in black box labels. Clin Pharmacol Ther (2002) 1.38

Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis (2003) 1.37

Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. J Dev Behav Pediatr (2010) 1.36

Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34

Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis (2004) 1.32

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31

The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol (2008) 1.30

A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol (2003) 1.29

In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDS (2011) 1.26

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25

Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol (2004) 1.25

Combination antiretroviral use and preterm birth. J Infect Dis (2012) 1.25

Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf (2007) 1.25

Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf (2007) 1.23

The urban spread of visceral leishmaniasis: clues from spatial analysis. Epidemiology (2002) 1.20

Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons. J Dev Behav Pediatr (2012) 1.20

The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiol Drug Saf (2006) 1.20

Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol (2007) 1.19

Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf (2002) 1.16

A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis (2003) 1.16

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr Adolesc Med (2009) 1.16

Maternal periodontitis and adverse pregnancy outcomes. Community Dent Oral Epidemiol (2008) 1.15

Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study. JAMA Pediatr (2013) 1.15

Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care (2011) 1.13

Predictors of serum dioxins and PCBs among peripubertal Russian boys. Environ Health Perspect (2009) 1.11

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr (2009) 1.11

Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis (2008) 1.10

Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children. AIDS Res Hum Retroviruses (2011) 1.09

Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf (2006) 1.09

Do-not-resuscitate orders and/or hospice care, psychological health, and quality of life among children/adolescents with acquired immune deficiency syndrome. J Palliat Med (2008) 1.09

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children. J Acquir Immune Defic Syndr (2008) 1.09

A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf (2008) 1.09

Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected. J Dev Behav Pediatr (2012) 1.08

Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol (2002) 1.07

Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants. Pediatr Infect Dis J (2013) 1.06

Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia. Clin Ther (2005) 1.05

Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J (2013) 1.05

Severe vascular events in migraine patients. Headache (2004) 1.04

Association of blood lead levels with onset of puberty in Russian boys. Environ Health Perspect (2008) 1.03

Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry (2002) 1.01

Indoor and outdoor measurements of particle number concentration in near-highway homes. J Expo Sci Environ Epidemiol (2013) 1.01

The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome. Dig Dis Sci (2005) 1.01

Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clin Infect Dis (2013) 1.00

Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. Pediatr Infect Dis J (2012) 0.99

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. Pediatr Infect Dis J (2010) 0.97

Serum dioxins and polychlorinated biphenyls are associated with growth among Russian boys. Pediatrics (2010) 0.97

Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors. Pediatr Infect Dis J (2009) 0.96

Urinary Phthalate Metabolite Concentrations and Reproductive Outcomes among Women Undergoing in Vitro Fertilization: Results from the EARTH Study. Environ Health Perspect (2015) 0.96

The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments. Reprod Toxicol (2013) 0.96

Development of a clinical guideline to predict undiagnosed diabetes in dental patients. J Am Dent Assoc (2011) 0.95

Identification of abacavir hypersensitivity reaction in health care claims data. Pharmacoepidemiol Drug Saf (2007) 0.95

Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth. AIDS (2010) 0.95

Antidepressant use and risk for preeclampsia. Epidemiology (2013) 0.95

Dioxin exposure and age of pubertal onset among Russian boys. Environ Health Perspect (2011) 0.95

Periodontitis and plasma C-reactive protein during pregnancy. J Periodontol (2006) 0.94

Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus. Circulation (2013) 0.94